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Available online 2 June 2012AbstractDisseminated histoplasmosis can be extremely life threatening if not identified and treated promptly. Diagnosing fungal infections in patients
receiving solid organ transplants and in those who are immunosuppressed is pivotal in prevention of fungal sepsis. These patients may present
with subtle chronic symptoms prior to sepsis. The patient, a 77-year-old woman who had a kidney transplant from a living related donor about 26
years previously, presented with recurrent skin rash and muscle weakness for 4 months. Her skin biopsy showed nonspecific granulomas prior to
admission. On presentation she remained critically ill, and her radiographic imaging or cultures did not show specific abnormalities throughout
the disease course, except for a positive urine histoplasma antigen and serum histoplasma polymerase chain reaction. Her clinical status
deteriorated eventually leading to death. This case highlights the importance of rapid diagnostic tests in the early diagnosis of disseminated
histoplasmosis, which could potentially prevent fulminant sepsis.
Copyright  2012, Taiwan Society of Emergency Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
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Certain infections in renal transplant patients may have an
atypical symptomatic presentation secondary to immunosup-
pression. Histoplasmosis is found all over the world, although
it is mostly predominant in the midwestern United States and
Central America.1,2 Generally, the presentation in immuno-
competent patients varies. In immunocompromised patients
with histoplasmosis, the disease does not follow a defined
pattern, and patients may exhibit an array of clinical symptoms
like fever, weight loss, pneumonitis, cough, and lymphatic
tissue enlargement.2,3 Disseminated histoplasmosis is a life
threatening infection and requires early diagnosis and prompt
treatment.* Corresponding author. 4401 Wornall Road, Kansas City, Missouri 64111,
United States.
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doi:10.1016/j.jacme.2012.03.002We report a patient with disseminated histoplasmosis who
presented with recurrent skin rash and proximal muscle
weakness for 4 months prior to development of sepsis.
2. Case report
A 77-year-old woman who had a renal transplant from
a living related donor about 26 years previously was referred
to our tertiary care center from the rural Midwest region of the
United States. Her renal history was significant for end-stage
renal disease from polycystic kidney disease. She also had
a history of fibromyalgia. Her primary complaints included
a bilateral lower extremity skin rash and proximal muscle
weakness for approximately 4 months. A painful pruritic rash
with indurated plaques was more prominent on the left lower
extremity than the right. She had episodes of spontaneous
remission and recurrence of symptoms. Her records showed
a history of multiple admissions to an outside facility for the
same symptoms, where she was presumably treated for
cellulitis. Laboratory tests were not indicative of anyMedicine. Published by Elsevier Taiwan LLC. All rights reserved.
Fig. 2. Chest roentgenogram shows a right basilar subsegmental atelectasis and
a very small left pleural effusion.
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had a normal blood cell count during these admissions.
She was on immunosuppression therapy, including azathio-
prine and prednisone. A skin biopsy performed about 1 month
prior to her admission had demonstrated granulomas, although
all special stains showed no abnormalities. An increase in
mucin was observed throughout the subcutaneous fat. After
consultations with three different dermatopathologists, a likely
infectious etiology was derived, although an autoimmune
etiology could not be ruled out (Fig. 1). The autoimmune
examination, which included rheumatoid factor, anti-
ribonucleoprotein antibodies, anticyclic citrullinated protein
antibodies, antinuclear antibodies, antidouble-stranded DNA
antibodies, cytoplasmic antineutrophil cytoplasmic antibodies,
perinuclear antineutrophil cytoplasmic antibodies, and anti Jo-1
antibodies, showed no abnormalities.
On presentation, she had a high grade 38.8 C fever. She
was then started on broad-spectrum antibiotics, vancomycin
15 mg/kg intravenously every 8 hours, and piperacillin/tazo-
bactam 3.375 mg intravenously every 6 hours. Her complete
blood count results ranged as follows: platelets, 97e50 109/
L; white blood cells, 4.5e2.4 109/L; hemoglobin
10.1e9.0 g/dL; creatine kinase 1.70 U/L (0e2.37 U/L); and
thyroid stimulating hormone 1.94 mIU/L.
Blood and sputum cultures were negative. Roentgenog-
raphy of the chest showed essentially insignificant for any
specific finding (Fig. 2). Computerized tomography of the
chest showed no infiltrates or lymphadenopathy. On the
following day, she had hypotension and atrial fibrillation. On
examination, she was found to be hemodynamically unstable
and was treated with mechanical ventilation. After intubation,
she underwent a bronchoscopy. A silver stain revealed
a budding yeast infection, fungal organisms consistent with
Candida and atypical squamous cells, and, hence, she was also
started on antifungal intravenous fluconazole 400 mg
empirically.Fig. 1. A hematoxylin and eosin stain of the skin biopsy demonstrating two
granulomas, one at 12 o’clock and the other at 6 o’clock. Also shown is the
lymphocytic inflammation. An increase in mucin is observed throughout the
subcutaneous fat.Histoplasma antigen in the urine was elevated to more than
39 enzyme immunoassay (EIA) units (reference range: < 2.0
EIA units). Her antifungal therapy was then immediately
changed to intravenous amphotericin B to 1 mg/kg per day.
She continued to require vasopressor support and
mechanical ventilation. Aggressive supportive measures were
discontinued as per the patient’s wish and the family’s deci-
sion on the second day. She became hemodynamically
unstable and died the same night. Bone marrow biopsy reports
after the patient’s death showed megakaryocytes, no lym-
phoproliferative disorder, and a fungal yeast infection
consistent with histoplasmosis. Her serum DNA probe test was
positive for histoplasma. Fungal blood cultures remained
negative throughout the course of the disease.3. Discussion
Histoplasmosis is also known as Ohio Valley fever. Its
causative organism, Histoplasma capsulatum, is seen all over
the world. It is common in Central America and the United
States (most predominantly in Ohio, Mississippi, and the
Midwest).1,2 Clinically, it may present with variable clinical
symptoms like fever, weight loss, cough, pneumonitis, and
lymphatic tissue enlargement.2,3 In a multicentric study the
cumulative incidence of endemic fungal infections was 0.50%.
The combined incidence of blastoplasmosis and histoplas-
mosis was less than 1% (median time to disease onset after
transplant was 10.5 months).4
Histoplasma is a dimorphic fungus and the infection is
acquired by inhalation of conidia. Infection can be acquired
from inhalation of these conidia, which are commonly present
in cave-dwelling bats and soils inhabited by chickens.5
Histoplasmosis has various forms of presentation ranging
from being asymptomatic to cutaneous manifestations like
panniculitis and myositis.6 Cutaneous manifestations of
histoplasmosis have been reported, especially in transplant
recipients,7 but our case was unique because it presented 26
years after a renal transplant. Urinary histoplasma antigen has
very high sensitivity and specificity, and it is very useful as
a diagnostic tool,8 especially since the results of fungal
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a polymerase chain reaction of whole blood plays a significant
role in the facilitation of diagnosis even when blood cultures
are negative.9 Amphotericin B is reserved for the initial
treatment of moderately severe or severe infection because of
its potential toxicity.10 Oral therapy with itraconazole is
appropriate for patients not requiring hospitalization and for
continuation of outpatient therapy in those initially treated
with amphotericin B.10
4. Conclusion
This case highlights the importance of urinary histoplas-
mosis antigen as a rapid diagnostic tool. Immunosuppression
puts renal transplant patients at a risk of developing opportu-
nistic and fungal infections.
Early consideration of histoplasmosis in immunosuppressed
patients, especially in endemic regions, can help prevent devas-
tating effects from otherwise treatable infectious etiologies.
In this case, the patient’s skin biopsy showed granulomas
but all special stains were negative for any organisms. She had
fibromyalgia that also added to the challenge in early diag-
nosis. Obtaining a urine histoplasma antigen and DNA probe
may have helped in the early diagnosis and treatment of the
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